Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sorrento Therapeutics Inc (SRNE)

  7. Sorrento Therapeutics Inc (SRNE) Financials

SRNE

Sorrento Therapeutics Inc

0.3073
0.00 (0.0%)
Upgrade to Real-Time

Sorrento Therapeutics Inc. (SRNE) Fundamentals
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for the treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody-drug conjugates.
SHARE INFORMATION
Market Cap$ 211,153,055
Shares Outstanding547,880,267
Float543,180,006
Percent Float99.14%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 52,904,000
Latest Fiscal EPS$ -1.43
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions389
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months40,416,089
Institutional Holdings Percent65.8%
Institutional Sold Previous 3 Months6,390,233
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months500
Insider Holdings Percent19.9
Insider Sold Previous 3 Months5
Insider Shares Owned108,966,178
TRADING INFO
52 Week High$ 3.09
52 Week Low$ 0.16
52 Week High Change$ -86.48
21 Day Moving Average$ 0.7852
21 Day Extended Moving Average$ 0.689674
50 Day Moving Average$ 0.9224
50 Day Extended Moving Average$ 0.919959
200 Day Moving Average$ 1.6213
200 Day Extended Moving Average$ 1.8111
10 Day Average Volume134,172,990
20 Day Average Volume73,778,368
30 Day Average Volume52,590,681
50 Day Average Volume37,224,170
Alpha0.001668
Beta1.9429
Standard Deviation0.361733
R20.084166
7 Day Price Change$ 0.1879
7 Day Percent Change95.14%
21 Day Price Change$ -0.5731
21 Day Percent Change-59.79%
30 Day Price Change$ -0.7046
30 Day Percent Change-64.64%
Month to Date Price Change$ -0.5731
Month to Date Percent Change-59.79%
Quarter to Date Price Change$ -0.5006
Quarter to Date Percent Change-56.5%
180 Day Price Change$ -1.47
180 Day Percent Change-79.28%
200 Day Price Change$ -2.37
200 Day Percent Change-86.04%
Year to Date Price Change$ -0.5006
Year to Date Percent Change-56.5%

Sorrento Therapeutics Inc. (SRNE) Key Ratios

PROFITABILITY
EBIT Margin-862.1%
EBITDA Margin-840.9%
Pre-Tax Profit Margin-1,130.6%
Profit Margin Count0.0%
Gross Margin62.1%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 47,245,000
Revenue Per Share$ 0.0862
Revenue (3 Years)$ 16.24
Revenue (5 Years)$ -12.08
FINANCIAL STRENGTH
Price to Tangible Book-1.40
Total Debt To Equity1.30
Int Coverage-55.90
Current Ratio0.90
Leverage Ratio4.30
Quick Ratio0.70
Long Term Debt To Capital0.44
VALUATION MEASURES
PE Ratio-0.20
Enterprise Value$ 220,194,882
Price to Sales4.4693
Price to Free Cash-0.70
PE High Last 5 Years266.30
Price To Book1.30
Price To Cash Flow0.00
PE Low Last 5 Years-3.60
Price to Tangible Book-1.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.00
Invoice Turnover1.10
Assets Turnover0.00
Return Assets-72.14
Return on Equity-374.84
Return on Capital-152.93

Sorrento Therapeutics Inc. (SRNE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOHenry Ji
Employees799
Last AuditUE
CIK0000850261
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address4955 Directors Place
San Diego, CA 92121
Websitehttps://www.sorrentotherapeutics.com
Facsimile+1 858 203-4028
Telephone+1 858 203-4100
Emailinvestors@sorrentotherapeutics.com


Your Recent History
NASDAQ
SRNE
Sorrento T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.